Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.